Web monitoring for capturing real-world feedback on drugs
First live demo of PLG’s powerful new AI-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
ProductLife Group (PLG) is to host a webinar on the growing importance of web monitoring as a source of timely, real-world product feedback for drugs companies. The short session, which will take place on 26 April at 2:00PM CET, will include the first live demo of PLG’s powerful new artificial-intelligence-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
During the webinar, AI experts will explore the unique scope of web forums and public social media channels for monitoring consumers’ real-world experience of life sciences products, and to build up an early picture of potential adverse effects. Although the life sciences industry has long understood the potential for timely insight at large scale offered by web and social media listening, the issue until now has been how to monitor these digital channels in an efficient and reliable way to distil the findings that matter - and to do this in a way that respects people’s privacy
.The session will include a first, exclusive look at PLG inVolv via a live demo of the new artificial-intelligence (AI)-based solution, which meets these important criteria. Crucially, it uses machine learning to adapt to the kinds of findings life sciences organisations are most interested in, so that professionals do not waste time looking at content that isn’t of value.
PLG inVolv, which is provided via a software-as-a-service (SaaS) delivery model and is designed to complement rather than replace existing product vigilance and clinical safety systems, is the result of an exclusive partnership with Volv, a specialist in AI-based social listening technology for life sciences.
The webinar, which will run for half an hour, is open to a limited number of participants to allow enough time for a Q&A session following the demonstration. Commenting on the event, Adam Sherlock, CEO of ProductLife Group, said: “Social listening in life sciences, especially in the context of safety and pharmacovigilance, is a hugely hot topic at the moment. Companies are under increasing pressure to proactively track the impact of their products in the market, and what better way than with the help of machine learning and targeted web and social listening? This webinar is very timely, and we expect the session to be over-subscribed.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.